End Stage Renal Disease (ESRD)
58
11
16
29
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
13 trials with published results (22%)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
3.4%
2 terminated out of 58 trials
93.5%
+7.0% vs benchmark
14%
8 trials in Phase 3/4
45%
13 of 29 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 29 completed trials
Clinical Trials (58)
Multi-Site STARgraft (10401) Trial
A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment
Probiotic and Synbiotic Supplements in Hemodialysis Patients
Expanded Hemodialysis Versus High-Volume Online Hemodiafiltration for Uremic Toxin Removal
Effect of a Plant-Focused Diet on Nutritional Status in Malnourished Peritoneal Dialysis Patients
AVF Stenosis by Electronic Stethoscope
Pivotal Study of the Velocity™ pAVF System
EndoForce Post Approval Study
Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
Impact of APP-assisted Patient Management on the Quality Control of Blood Purification Therapy
TRT as an Adjunctive ERAS Therapy in ESRD Patients Undergoing Kidney Transplantation
The Effect of Geranium Essential Oil Aromatherapy on Fatigue and Sleep Quality in Patients Undergoing Hemodialysis
Anesthetic Effect of Ropivacaine on Local Infiltration Anesthesia in Arteriovenous Fistula Surgery
The Effect of Exercise on Low Back Pain in Peritoneal Dialysis Patients
Effect of Modifying Magnesium Concentration in Citrate-enriched Dialysate on Hemodialysis-associated Thromboinflammation
RaDIANT Health Systems Intervention
Prevalence of Latent Tuberculosis Infection Among Hemodialysis Patients
Early Feasibility Study of the Velocity™ Percutaneous Arterio-Venous Fistula System for Creating Hemodialysis Vascular Access
Activated Charcoal Use in Chronic Kidney Disease Patients